Loading…
Kinetics of 1,2-dinitroglycerin following sustained release nitroglycerin: influence of propranolol and metoprolol
Ten healthy volunteers ingested a single 18-mg oral dose of sustained release nitroglycerin (TNG) (Giulini-Pharma) on three occasions: once in the control state, once during coadministration of propranolol (80-mg three times daily), and once during coadministration of metoprolol (100-mg twice daily)...
Saved in:
Published in: | Klinische Wochenschrift 1985-11, Vol.63 (22), p.1170-1173 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c282t-df69c05fed99394cfef40008f73fa39b1b1ca7da56520d2144f0738c3c57cf683 |
---|---|
cites | cdi_FETCH-LOGICAL-c282t-df69c05fed99394cfef40008f73fa39b1b1ca7da56520d2144f0738c3c57cf683 |
container_end_page | 1173 |
container_issue | 22 |
container_start_page | 1170 |
container_title | Klinische Wochenschrift |
container_volume | 63 |
creator | Ochs, H R Verburg-Ochs, B Greenblatt, D J |
description | Ten healthy volunteers ingested a single 18-mg oral dose of sustained release nitroglycerin (TNG) (Giulini-Pharma) on three occasions: once in the control state, once during coadministration of propranolol (80-mg three times daily), and once during coadministration of metoprolol (100-mg twice daily). The degree of beta adrenergic blockade was evaluated by the metaproterenol infusion test. Plasma concentration of TNG and its major metabolite, 1,2-dinitroglycerin (DNG), during 12 h after each dose were measured by gas chromatography-mass spectrometry. Intact TNG was not detected in the plasma of any patient. The major metabolite, DNG, was easily measurable in blood, and had a biphasic plasma concentration profile. Coadministration of the beta-blockers had no influence on any of the kinetic variables for DNG. The mean values during control, propranolol, and metoprolol trials of DNG elimination half-life were: 1.35, 1.10, and 1.09 h; total area under the curve: 42, 38, and 42 ng/ml X h; oral clearance: 6.6, 7.2, and 6.4 liters/min. Thus TNG when administered as a sustained release oral preparation is rapidly and completely transformed to DNG. There was no pharmacokinetic interaction between sustained release TNG and two commonly used beta-blocking agents, suggesting that any clinical interaction that may-occur between sustained release nitroglycerin and beta-blocking agents is pharmacodynamic rather than pharmacokinetic in nature. |
doi_str_mv | 10.1007/BF01740593 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF01740593</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3935852</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-df69c05fed99394cfef40008f73fa39b1b1ca7da56520d2144f0738c3c57cf683</originalsourceid><addsrcrecordid>eNpVkE1LAzEURYMotVY37oWsxdGXZDKZcafFqlhwo-shzUeJpMmQzCD9905pUVw97uNw4R6ELgncEgBx97gAIkrgDTtCU1IyWpCyhGM0BaCsoESwU3SW8xcAp0JUEzRhDeM1p1OU3lwwvVMZR4vJDS20C65Pce23yiQXsI3ex28X1jgPuZcjrXEy3shs8D_yHrtg_WCCMruuLsUuyRB99FgGjTemHx-7eI5OrPTZXBzuDH0unj7mL8Xy_fl1_rAsFK1pX2hbNQq4NbppWFMqa2wJALUVzErWrMiKKCm05BWnoOm42IJgtWKKC2Wrms3Q9b5XpZhzMrbtktvItG0JtDtv7Z-3Eb7aw92w2hj9ix5EsR-YK2pt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Kinetics of 1,2-dinitroglycerin following sustained release nitroglycerin: influence of propranolol and metoprolol</title><source>Springer Nature - Connect here FIRST to enable access</source><creator>Ochs, H R ; Verburg-Ochs, B ; Greenblatt, D J</creator><creatorcontrib>Ochs, H R ; Verburg-Ochs, B ; Greenblatt, D J</creatorcontrib><description>Ten healthy volunteers ingested a single 18-mg oral dose of sustained release nitroglycerin (TNG) (Giulini-Pharma) on three occasions: once in the control state, once during coadministration of propranolol (80-mg three times daily), and once during coadministration of metoprolol (100-mg twice daily). The degree of beta adrenergic blockade was evaluated by the metaproterenol infusion test. Plasma concentration of TNG and its major metabolite, 1,2-dinitroglycerin (DNG), during 12 h after each dose were measured by gas chromatography-mass spectrometry. Intact TNG was not detected in the plasma of any patient. The major metabolite, DNG, was easily measurable in blood, and had a biphasic plasma concentration profile. Coadministration of the beta-blockers had no influence on any of the kinetic variables for DNG. The mean values during control, propranolol, and metoprolol trials of DNG elimination half-life were: 1.35, 1.10, and 1.09 h; total area under the curve: 42, 38, and 42 ng/ml X h; oral clearance: 6.6, 7.2, and 6.4 liters/min. Thus TNG when administered as a sustained release oral preparation is rapidly and completely transformed to DNG. There was no pharmacokinetic interaction between sustained release TNG and two commonly used beta-blocking agents, suggesting that any clinical interaction that may-occur between sustained release nitroglycerin and beta-blocking agents is pharmacodynamic rather than pharmacokinetic in nature.</description><identifier>ISSN: 0023-2173</identifier><identifier>EISSN: 1432-1440</identifier><identifier>DOI: 10.1007/BF01740593</identifier><identifier>PMID: 3935852</identifier><language>eng</language><publisher>Germany</publisher><subject>Adult ; Biotransformation ; Delayed-Action Preparations ; Drug Interactions ; Humans ; Kinetics ; Metabolic Clearance Rate - drug effects ; Metoprolol - pharmacology ; Nitroglycerin - administration & dosage ; Nitroglycerin - blood ; Propranolol - pharmacology</subject><ispartof>Klinische Wochenschrift, 1985-11, Vol.63 (22), p.1170-1173</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c282t-df69c05fed99394cfef40008f73fa39b1b1ca7da56520d2144f0738c3c57cf683</citedby><cites>FETCH-LOGICAL-c282t-df69c05fed99394cfef40008f73fa39b1b1ca7da56520d2144f0738c3c57cf683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3935852$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ochs, H R</creatorcontrib><creatorcontrib>Verburg-Ochs, B</creatorcontrib><creatorcontrib>Greenblatt, D J</creatorcontrib><title>Kinetics of 1,2-dinitroglycerin following sustained release nitroglycerin: influence of propranolol and metoprolol</title><title>Klinische Wochenschrift</title><addtitle>Klin Wochenschr</addtitle><description>Ten healthy volunteers ingested a single 18-mg oral dose of sustained release nitroglycerin (TNG) (Giulini-Pharma) on three occasions: once in the control state, once during coadministration of propranolol (80-mg three times daily), and once during coadministration of metoprolol (100-mg twice daily). The degree of beta adrenergic blockade was evaluated by the metaproterenol infusion test. Plasma concentration of TNG and its major metabolite, 1,2-dinitroglycerin (DNG), during 12 h after each dose were measured by gas chromatography-mass spectrometry. Intact TNG was not detected in the plasma of any patient. The major metabolite, DNG, was easily measurable in blood, and had a biphasic plasma concentration profile. Coadministration of the beta-blockers had no influence on any of the kinetic variables for DNG. The mean values during control, propranolol, and metoprolol trials of DNG elimination half-life were: 1.35, 1.10, and 1.09 h; total area under the curve: 42, 38, and 42 ng/ml X h; oral clearance: 6.6, 7.2, and 6.4 liters/min. Thus TNG when administered as a sustained release oral preparation is rapidly and completely transformed to DNG. There was no pharmacokinetic interaction between sustained release TNG and two commonly used beta-blocking agents, suggesting that any clinical interaction that may-occur between sustained release nitroglycerin and beta-blocking agents is pharmacodynamic rather than pharmacokinetic in nature.</description><subject>Adult</subject><subject>Biotransformation</subject><subject>Delayed-Action Preparations</subject><subject>Drug Interactions</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Metabolic Clearance Rate - drug effects</subject><subject>Metoprolol - pharmacology</subject><subject>Nitroglycerin - administration & dosage</subject><subject>Nitroglycerin - blood</subject><subject>Propranolol - pharmacology</subject><issn>0023-2173</issn><issn>1432-1440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LAzEURYMotVY37oWsxdGXZDKZcafFqlhwo-shzUeJpMmQzCD9905pUVw97uNw4R6ELgncEgBx97gAIkrgDTtCU1IyWpCyhGM0BaCsoESwU3SW8xcAp0JUEzRhDeM1p1OU3lwwvVMZR4vJDS20C65Pce23yiQXsI3ex28X1jgPuZcjrXEy3shs8D_yHrtg_WCCMruuLsUuyRB99FgGjTemHx-7eI5OrPTZXBzuDH0unj7mL8Xy_fl1_rAsFK1pX2hbNQq4NbppWFMqa2wJALUVzErWrMiKKCm05BWnoOm42IJgtWKKC2Wrms3Q9b5XpZhzMrbtktvItG0JtDtv7Z-3Eb7aw92w2hj9ix5EsR-YK2pt</recordid><startdate>19851115</startdate><enddate>19851115</enddate><creator>Ochs, H R</creator><creator>Verburg-Ochs, B</creator><creator>Greenblatt, D J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19851115</creationdate><title>Kinetics of 1,2-dinitroglycerin following sustained release nitroglycerin: influence of propranolol and metoprolol</title><author>Ochs, H R ; Verburg-Ochs, B ; Greenblatt, D J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-df69c05fed99394cfef40008f73fa39b1b1ca7da56520d2144f0738c3c57cf683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Adult</topic><topic>Biotransformation</topic><topic>Delayed-Action Preparations</topic><topic>Drug Interactions</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Metabolic Clearance Rate - drug effects</topic><topic>Metoprolol - pharmacology</topic><topic>Nitroglycerin - administration & dosage</topic><topic>Nitroglycerin - blood</topic><topic>Propranolol - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ochs, H R</creatorcontrib><creatorcontrib>Verburg-Ochs, B</creatorcontrib><creatorcontrib>Greenblatt, D J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Klinische Wochenschrift</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ochs, H R</au><au>Verburg-Ochs, B</au><au>Greenblatt, D J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kinetics of 1,2-dinitroglycerin following sustained release nitroglycerin: influence of propranolol and metoprolol</atitle><jtitle>Klinische Wochenschrift</jtitle><addtitle>Klin Wochenschr</addtitle><date>1985-11-15</date><risdate>1985</risdate><volume>63</volume><issue>22</issue><spage>1170</spage><epage>1173</epage><pages>1170-1173</pages><issn>0023-2173</issn><eissn>1432-1440</eissn><abstract>Ten healthy volunteers ingested a single 18-mg oral dose of sustained release nitroglycerin (TNG) (Giulini-Pharma) on three occasions: once in the control state, once during coadministration of propranolol (80-mg three times daily), and once during coadministration of metoprolol (100-mg twice daily). The degree of beta adrenergic blockade was evaluated by the metaproterenol infusion test. Plasma concentration of TNG and its major metabolite, 1,2-dinitroglycerin (DNG), during 12 h after each dose were measured by gas chromatography-mass spectrometry. Intact TNG was not detected in the plasma of any patient. The major metabolite, DNG, was easily measurable in blood, and had a biphasic plasma concentration profile. Coadministration of the beta-blockers had no influence on any of the kinetic variables for DNG. The mean values during control, propranolol, and metoprolol trials of DNG elimination half-life were: 1.35, 1.10, and 1.09 h; total area under the curve: 42, 38, and 42 ng/ml X h; oral clearance: 6.6, 7.2, and 6.4 liters/min. Thus TNG when administered as a sustained release oral preparation is rapidly and completely transformed to DNG. There was no pharmacokinetic interaction between sustained release TNG and two commonly used beta-blocking agents, suggesting that any clinical interaction that may-occur between sustained release nitroglycerin and beta-blocking agents is pharmacodynamic rather than pharmacokinetic in nature.</abstract><cop>Germany</cop><pmid>3935852</pmid><doi>10.1007/BF01740593</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0023-2173 |
ispartof | Klinische Wochenschrift, 1985-11, Vol.63 (22), p.1170-1173 |
issn | 0023-2173 1432-1440 |
language | eng |
recordid | cdi_crossref_primary_10_1007_BF01740593 |
source | Springer Nature - Connect here FIRST to enable access |
subjects | Adult Biotransformation Delayed-Action Preparations Drug Interactions Humans Kinetics Metabolic Clearance Rate - drug effects Metoprolol - pharmacology Nitroglycerin - administration & dosage Nitroglycerin - blood Propranolol - pharmacology |
title | Kinetics of 1,2-dinitroglycerin following sustained release nitroglycerin: influence of propranolol and metoprolol |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T07%3A01%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kinetics%20of%201,2-dinitroglycerin%20following%20sustained%20release%20nitroglycerin:%20influence%20of%20propranolol%20and%20metoprolol&rft.jtitle=Klinische%20Wochenschrift&rft.au=Ochs,%20H%20R&rft.date=1985-11-15&rft.volume=63&rft.issue=22&rft.spage=1170&rft.epage=1173&rft.pages=1170-1173&rft.issn=0023-2173&rft.eissn=1432-1440&rft_id=info:doi/10.1007/BF01740593&rft_dat=%3Cpubmed_cross%3E3935852%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c282t-df69c05fed99394cfef40008f73fa39b1b1ca7da56520d2144f0738c3c57cf683%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/3935852&rfr_iscdi=true |